Výsledky vyhledávání

Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group

Autor: J R, Guyton, M A, Blazing, J, Hagar, M L, Kashyap, R H, Knopp, J M, McKenney, D T, Nash, S D, Nash

Publikováno v: Archives of internal medicine. 160(8)

To provide a direct comparison of agents that raise plasma levels of high-density lipoprotein cholesterol (HDL-C) to help devise strategies for coronary risk reduction.In a multicenter, randomized, double-blind trial, we compared the effects of exten

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7b9b3c9f2bc0d2c270c8fef1e1b31ff9
https://pubmed.ncbi.nlm.nih.gov/10789612

Zobrazit plný text záznamu

Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events

Autor: M A, Pfeffer, F M, Sacks, L A, Moyé, C, East, S, Goldman, D T, Nash, J R, Rouleau, J L, Rouleau, B A, Sussex, P, Theroux, R J, Vanden Belt, E, Braunwald

Publikováno v: Journal of the American College of Cardiology. 33(1)

We sought to assess the influence of baseline lipid levels on coronary event rates and the effectiveness of pravastatin therapy in the Cholesterol And Recurrent Events (CARE) study.The CARE study cohort provided a relatively unique opportunity to exa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4d456ceaccc2cadf77b1f7100a5de24b
https://pubmed.ncbi.nlm.nih.gov/9935018

Zobrazit plný text záznamu

Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism

Autor: D. T. Nash

Publikováno v: Clinical cardiology. 13(11)

The sympathetic nervous system plays a major role in the pathogenesis of essential hypertension and is mediated by the alpha and beta receptors. The alpha receptor is divided into two types, alpha 1 and alpha 2, based on response to epinephrine and n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68dd5069134058cb0d6f914c5e487f83
https://pubmed.ncbi.nlm.nih.gov/1980236

Zobrazit plný text záznamu

Effect of high-chromium brewer's yeast on human serum lipids

Autor: D T Nash, J C Elwood, D H Streeten

Publikováno v: Journal of the American College of Nutrition. 1:263-274

A group of 11 normolipidemic and a group of 16 hyperlipidemic adult subjects were given orally 20 gm daily of a high-chromium brewer's yeast (2.4 micrograms Cr+++/gm, ie, 48 micrograms Cr+++ daily) for 8 weeks. A significant decrease in total cholest

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb6fc29e054273702d1baa34d4609d40
https://doi.org/10.1080/07315724.1982.10718995

Zobrazit plný text záznamu

The Erysichthon syndrome. Progression of coronary atherosclerosis and dietary hyperlipidemia

Autor: Goffredo G. Gensini, H Simon, D T Nash, T Arno, S D Nash

Publikováno v: Circulation. 56:363-365

One hundred nineteen patients with coronary artery disease confirmed by coronary arteriograms were studied. Cine coronary arteriography confirmed progression of atherosclerosis in 106 (89%) patients (mean age 50.9 yr) and nonprogression in 13 (11%) p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b081cfbde4195c05a16e22540cd25d4
https://doi.org/10.1161/01.cir.56.3.363

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání